跳至主要内容
临床试验/NCT03520283
NCT03520283已完成不适用

Use of Systems Support Mapping to Guide Patient-Driven Self-Management in Rural and Urban Cancer Survivors

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2018年5月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
24
试验地点
2
主要终点
Enrollment Rate

研究概览

简要总结

This pilot trial studies how well systems support mapping works in guiding self-management in stage I-III colorectal cancer survivors. Systems support mapping helps participants to see complex self-management activities on paper, which makes them more actionable. Behavioral interventions, such as systems support mapping, may help colorectal cancer survivors facilitate self-awareness, create motivation for behavior change, and guide self-management.

详细描述

PRIMARY OBJECTIVES:

I. To evaluate the feasibility of the systems support mapping (MAP) intervention in colorectal cancer survivors, as characterized by enrollment, intervention adherence, and retention rates.

SECONDARY OBJECTIVES:

I. To evaluate intervention acceptability as characterized by participant ratings.

II. To describe outcome variability to inform future studies. III. To identify multi-level contextual factors influencing self-management (SM).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with stage I-III colorectal cancer
  • Within 2 years of completing active treatment for colorectal cancer
  • Cognitively able to complete interviews as judged by the study team
  • Able to understand, read and write English

排除标准

  • Declined participation in the study

结局指标

主要结局

Enrollment Rate

时间窗: Up to 1 year

To be calculated as the percent of eligible participants approached who agree to participate. Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values. Rates will be summarized using point estimates and 95% confidence intervals.

Participation Rate

时间窗: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later

To be calculated as the percent of participants who complete the study intervention among those enrolled. Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values. Rates will be summarized using point estimates and 95% confidence intervals.

Retention Rate

时间窗: Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later

To be calculated as the proportion of participants who complete the study measures among those enrolled. Will use one-sample tests of negative binomial probabilities and binomial proportions to compare rates of feasibility to hypothesized values. Rates will be summarized using point estimates and 95% confidence intervals.

次要结局

  • Measures of Autonomy Assessed by Index of Autonomous Functioning(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Psychological Stress Assessed by Perceived Stress Scale(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Symptoms Assessed by Patient-Reported Outcomes Measurement Information System (PROMIS) Profile 29(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Self-reported Ratings of Intervention Acceptability(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Self-efficacy for Managing Cancer - Chronic Disease Scale(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Self-Efficacy for Managing Symptoms - Patient Reported Outcomes Measurement Information System (PROMIS) Short Form(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • PROMIS - Relatedness Assessed by Healing Encounters and Attitudes Lists (HEAL) Patient-Provider Connection(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Qualitative Analysis of Systems Support Maps(Up to 1 year)
  • Health Behaviors Assessed by Items on Tobacco Use(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Qualitative Assessment of Feasibility With Semi-structured Interviews(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Health Behaviors Assessed by Items on Use of Complementary Health Approaches(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Health Behaviors Assessed by Items on Physical Activity(Approximately 1.5-2 hours at baseline visit in clinic with a 2-week follow-up 2 weeks later)
  • Qualitative Assessment of Acceptability With Semi-structured Interviews(Up to 1 year)
  • Qualitative Assessment of Changes in Outcomes With Semi-structured Interviews(Up to 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Technology-enabled Patient Support System for Self-management of CFCystic Fibrosis
NCT03910881University of Alabama at Birmingham40
已完成
不适用
Harnessing Health IT for Self-Management Support and Medication Activation in a Medicaid Health PlanDiabetes
NCT00683020University of California, San Francisco362
已完成
不适用
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck CancerCaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Lip and Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell CarcinomaStage II Hypopharyngeal Squamous Cell CarcinomaStage II Laryngeal Squamous Cell CarcinomaStage II Lip and Oral Cavity Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Lip and Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IV Hypopharyngeal Squamous Cell CarcinomaStage IV Laryngeal Squamous Cell CarcinomaStage IV Lip and Oral Cavity Squamous Cell CarcinomaStage IV Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Lip and Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IVB Lip and Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Hypopharyngeal Squamous Cell CarcinomaStage IVC Laryngeal Squamous Cell CarcinomaStage IVC Lip and Oral Cavity Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal SCCRecurrent Paranasal Sinus Squamous Cell Carcinoma
NCT03032250Wake Forest University Health Sciences35
进行中(未招募)
不适用
Clinical Trial of a Group Self-management Support Program for Anxiety DisordersAgoraphobiaSocial Anxiety DisorderPanic DisorderGeneralized Anxiety Disorder
NCT05124639Université de Sherbrooke414
已完成
不适用
PainTracker Self-Manager: a Web-based Platform to Promote and Track Chronic Pain Self-managementChronic Pain
NCT03045081University of Washington99